Register Now +1 -212-400 - 6240 | www.exlpharma.com/EuroMSL

Featured Sessions Include:

2 0 - 2 1 O C T O B E R , 2 0 1 1 | K E M P I N S K I H O T E L B R I S T O L | B E R L I N , G E R M A N Y

Bringing Maximum Value to the KOL, Company, and Industry

Co-located with ExL Pharma’s4th European Investigator-Initiated Trials Conference: For Maximum Learning and Networking Opportunities

Featuring an Exceptional Faculty from These Industry Leaders:

NEW TECHNOLOGIES FOR MSLS TO ENGAGE WITH DOCTORSSUSANNE HARZER, Scientific Affairs Manager, Cardiovascular, SANOFI

THE PRODUCT LIFECYCLE: WHAT ROLE DOES THE MEDICAL SCIENCE MANAGER (MSM) HAVE THROUGHOUT THE PRODUCT LIFECYCLE?LUDOVIC HACOPIAN, Director, Field Medical Operations Director, Europe, BRISTOL-MYERS SQUIBB

MEASURING SUCCESS WITH KOLS: BUILDING RELATIONSHIPS AND MANAGING INTERACTIONS MIEKE VANDENBERGHE, MD MBA, Scientific Programmes & Communications Manager, Europe and Central Asia, MEDTRONIC

PANEL DISCUSSION: HOW IS THE RELATIONSHIP BETWEEN MSLS AND COMMERCIAL OPERATIONS EVOLVING?OZAN BATIGUN, Head of Medical Department, TEVASERDAR OZTURK, Medical Affairs Manager, NOVO NORDISKJONAS HYLTON, Associate Director, Medical Science Liaisons, CEPHALONDAVID GILLEN, Head of International Medical Affairs, GILEADMARIA JESSA, Medical manager, CHC, SANOFI

Medical & Scientific ADVISOR

MSL Summit

2ND EUROPEAN

Best Practices

and

MSL

Ozan Batigun, Head of Medical Department, TEVA

Nurhayat Buladi, Medical Scientific Liaison, MSD

Ian Forn Palacin, Regional Medical Manager/MSL, GRUNENTHAL

Tobias Gantner, Head of Market Access, BAYER

David Gillen, Head of International Medical Affairs, GILEAD

Amy Gomez, Medical Liaison Operations Consultant, ELI LILLY

Ludovic Hacopian, Director, Field Medical Operations Director, Europe, BRISTOL-MYERS SQUIBB

Susanne Harzer, Scientific Affairs Manager, Cardiovascular, SANOFI

Jonas Hylton, Associate Director, Medical Science Liaisons, CEPHALON

Maria Jessa, Medical Manager, CHC, SANOFI

Serdar Ozturk, Medical Affairs Manager, NOVO NORDISK

Chris Sugg, National Scientific Director - Managed Markets, NOVARTIS ONCOLOGY

Lincoln Tsang, Partner, ARNOLD & PORTER LLP

Marc Van Melckenbeke, Senior Global Director Medical Communications & Coordination, Global Medical Affairs, UCB

Mieke Vandenberghe, MD MBA, Scientific Programmes & Communications Manager, Europe and Central Asia, MEDTRONIC

Who Should Attend?From Pharmaceutical, Biotech, and Medical Device companies:

Medical Science Liaisons (MSL, MLs)

Medical and Scientific Advisors

Medical Managers and Scientists

Medical Development Advisors

Regional Scientific Services

Medical and Scientific Affairs

Medical Communications

Clinical Trial Liaisons

Clinical Research

Medical Education

Clinical/Outcomes Liaisons

Clinical Investigators

KOL Development

Business Intelligence

Regulatory Affairs

Marketing

This event is also of interest to:

Software Companies

Market Research Companies

Medical Communications

Consulting Agencies

Staffing Agencies and Recruiters

Dear Colleague,

I’m writing to introduce to you ExL Pharma’s 2nd European Medical & Scientific Advisor and MSL Best Practices Summit. Last year’s event featured insightful presentations on defining the role of the MSL, off-license information, and performance evaluation. But the MSL role in Europe is continually evolving, and it is essential for Medical Affairs professionals to keep current with how to best communicate internally and with the outside community. After the tremendous success of last year’s event, we’re excited to assemble a diverse, high-level faculty to discuss the most pressing issues in communicating accurate medical information to key stakeholders.

Our international speaker staff consists of leaders from pharmaceutical companies. MSL functions vary from country to country as much as they do company to company. Attendees at ExL Pharma’s 2nd European Medical & Scientific Advisor and MSL Best Practices Summit will have the opportunity to hear best practices and network with peers in a single location for two days.

I look forward to seeing you in Berlin this Fall.

Sincerely,

Dave HoffmanConference Directordhoffman@exlpharma.com

Matt MillmanDivision Head, Program Developmentmmillman@exlpharma.com

HOTEL INFO

KEMPINSKI HOTEL BRISTOL BERLINKURFÜRSTENDAMM 27 • 10719BERLIN, GERMANYPHONE: 49 3088 43 47 04

Located directly on the famous Kurfürstendamm boulevard, the “grande dame” amongst the Berlin hotels is unmistakably eye-catching with its striking semi-circular swung facade. Well-known figures and business travelers alike from all over the world appreciate the comfort, service, cuisine and cultural highlights in the Kempinski Hotel Bristol.

Room Reservations: If you require overnight accommodations, please contact the hotel and request the group rate for "ExL Pharma October" meetingWe encourage conference participants to make reservations by Wednesday 21st September 2011 with our designated venue as our discounted room rates are limited.

SPONSORSHIP AND EXHIBIT OPPORTUNITIESDo you want to spread the word about your organization’s solutions and services to potential clients who attend this event? Take advantage of the opportunity to exhibit, present an educational session, host a networking event, or distribute promotional items to attendees. ExL works closely with you to customize a package that suits all of your needs. To learn more about these opportunities, contact Eric Morrin, Business Development, by calling +1-212-400-6228 or by emailing emorrin@exlpharma.com.

Register Now +1 -212-400 - 6240 | www.exlpharma.com/EuroMSL

EXL PHARMACEUTICAL TRAINING DIVISIONLooking for a pharmaceutical training program that offers hands-on experience and are designed to fit your specific corporate needs? Contact Michael Goldberg at +1- 212-400-6244 or email mgoldberg@exlpharma.com for more details.

8:00 Registration and Continental Breakfast

9:00 PRE-CONFERENCE WORKSHOP: HOW TO DEVELOP INTERNAL GUIDELINES & PROCESSES TO ENSURE COMPLIANCE OF MSL PROGRAMS

Objectives• Why compliance matters • Consequences of non-compliance• Identifying key areas of risk and developing internal guidelines• Training and monitoring to ensure compliance• Strategies for creating global or regional standards for the role

A voting system will be used.

Workshop Leaders:MARC VAN MELCKENBEKE, Senior Global Director, Medical Communications &

Coordination, Global Medical Affairs, UCBAMY GOMEZ, Medical Liaison Operations Consultant, ELI LILLY

10:30 Refreshment and Networking Break

12:00 Workshop Concludes; Lunch for Workshop Attendees

MAIN CONFERENCE BEGINS | DAY ONE

12:00 Registration for Main Conference

Attendees

1:00 CHAIRPERSON’S INTRODUCTION

CHRIS SUGG, National Scientific Director - Managed

Markets, NOVARTIS ONCOLOGY

1:15 THE EVOLVING ROLE OF MSLS IN THE EUROPEAN MARKETPLACE

• What is the ideal MSL structure – local versus regional?• Medical Advisors, Scientific Advisors, and MSLs as medical spokespeople• Applying skill sets based on how medicine is delivered in a given country

SERDAR OZTURK, Medical Affairs Manager, NOVO NORDISK

2:00 PERFORMANCE METRICS: WHAT IS THE APPROPRIATE MEASURE OF MSL PERFORMANCE?

• How can medical departments demonstrate the value of their MSL activities

• Measuring frequency and reach versus assessing the quality of lasting relationships and company access

• Qualitative measurement – surveys• Demonstrating value beyond health and efficacy

JONAS HYLTON, Associate Director, Medical Science Liaisons,

CEPHALON

2:45 Networking and Refreshment Break

3:15 MSL PERFORMANCE FROM DIFFERENT PERSPECTIVES: HOW MAY EXPECTATIONS DIFFER BETWEEN DEPARTMENTS?

• What are the differences between MSLs and sales reps?• What is the relationship between medical managers and MSLs?• What do marketing/sales, market access, regulatory and clinical trial operations, and safety/PV expect from MSL?• What are the expectations from key opinion leaders and associations?• How do MSLs influence reimbursement committees or other payers?NURHAYAT BULADI, Medical Scientific Liaison, MSD

4:00 NEW TECHNOLOGIES FOR MSLS TO ENGAGE WITH DOCTORS

• Webex video conferencing• Doctors using the internet for research• How does social media facilitate or complicate MSLs’ relationships?• Using mobile technology for more accessibility

SUSANNE HARZER, Scientific Affairs Manager, Cardiovascular, SANOFI

4:45 ROUNDTABLE DISCUSSIONS: AUDIENCE MEMBERS SPLIT INTO SMALLER GROUPS FOR INTERACTIVE DISCUSSIONS OF KEY ISSUES. ATTENDEES WILL ALSO HAVE THE OPTION OF PARTICIPATING IN ROUNDTABLES WITH THE 4TH EUROPEAN INVESTIGATOR INITIATED TRIALS SUMMIT.

Working in the rare disease space with niche or orphan drugs CHRIS SUGG, National Scientific Director - Managed Markets, NOVARTIS ONCOLOGY

Tapping into research networksSUSANNE HARZER, Scientific Affairs Manager, Cardiovascular, SANOFI

Should Companies Think About Outsourcing MSLs?LUDOVIC HACOPIAN, Director, Field Medical Operations Europe, European Field Medical Centre of Excellence, BRISTOL-MYERS SQUIBB

Investing MSLs in emerging marketsMARIA JESSA, MEDICAL MANAGER, CHC, SANOFI

What is the impact of biosimilars on the MSL function?

For more information about our roundtable options, visit www.exlpharma.com/euromsl

5:15 Close of Day One

DAY ONE | THURSDAY, 20 OCTOBER, 2011

PR

E-C

ON

FE

RE

NC

E

WO

RK

SH

OP

Register Now +1 -212-400 - 6240 | www.exlpharma.com/EuroMSL

DAY TWO | FRIDAY, 21 OCTOBER, 2011

8:00 Continental Breakfast

9:00 CHAIRPERSON’S RECAP OF DAY ONE

MARC VAN MELCKENBEKE, Senior Global Director, Medical

Communications & Coordination, Global Medical Affairs, UCB

9:15 PANEL DISCUSSION: HOW IS THE RELATIONSHIP BETWEEN MSLS AND COMMERCIAL OPERATIONS EVOLVING?

• A discussion of the purpose and law of some European regulations• How does sales/marketing view the MSL role?• Is it appropriate to measure any kind of commercial ROI for MSL activities?• How to create an efficient working environment with sales and marketing

Moderator:OZAN BATIGUN, Head of Medical Department, TEVAPanelists:SERDAR OZTURK, Medical Affairs Manager, NOVO NORDISK

JONAS HYLTON, Associate Director, Medical Science Liaisons, CEPHALON

DAVID GILLEN, Head of International Medical Affairs, GILEAD

MARIA JESSA, Medical manager, CHC, SANOFI

10:00 OPPORTUNITIES FOR MSLS IN PRE AND POST LAUNCH REIMBURSEMENT STRATEGIES

• Evaluating the reimbursement outlook is critical to a products success and helps bring products to market of more value. This section will look at strategies where MSLs can contribute while the relationships with payers and providers are changing

• Key considerations when conducting a reimbursement analysis.• Reducing variability of care. Thinking beyond clinical guidelines• Advantages to building global market access teams

CHRIS SUGG, National Scientific Director - Managed Markets,

NOVARTIS ONCOLOGY

10:45 Networking and Refreshment Break

11:15 GRUNENTHAL CASE STUDY: SUCCESSFULLY CREATING A ROLE FOR MSLS IN THE SPANISH MARKET

• Determining the function MSLs will play in your company and the industry• Establishing credibility among the rest of the company regarding MSLs• Setting benchmarks to measure success for the MSL program

IAN FORN PALACIN, Regional Medical Manager/MSL,

GRUNENTHAL

12:00 THE PRODUCT LIFECYCLE: WHAT ROLE DOES THE MEDICAL SCIENCE MANAGER (MSM) HAVE THROUGHOUT THE PRODUCT LIFECYCLE?

• What is the product lifecycle and what are the associated field medical activities?

• What are the different approaches to lifecycle flexing?• What are the implications of lifecycle flexing ?

LUDOVIC HACOPIAN, Director, Field Medical Operations Director,

Europe, BRISTOL-MYERS SQUIBB

12:45 Luncheon

1:45 KOL LANDSCAPE: HOW IS THE MSL/KOL RELATIONSHIP EVOLVING?

• How will disclosure of payments affect the KOL industry?• Identifying and approaching KOLs• Customer or business partner; expectations of both parties• Evaluating KOL performance

OZAN BATIGUN, Head of Medical Department, TEVA

2:45 MEASURING SUCCESS WITH KOLS: BUILDING RELATIONSHIPS AND MANAGING INTERACTIONS

• Gathering field insights through responsive inquiry to guide future interactions and ensure working in tandem with the sales team

• Identifying key performance indicators (KPIs) and clarifying goals for the KOL relationship

• How to track MSL contacts for KOLs• Clarifying the goals of the KOLs and understanding how they

align with your company’s goalsMIEKE VANDENBERGHE, MD MBA, Scientific Programmes &

Communications Manager, Europe and Central Asia, MEDTRONIC

3:30 Networking and Refreshment Break

4:00 MARKET ACCESS CASE STUDY: THE ROLE OF MSL DRIVEN ADVOCACY IN A MANAGED MARKET: A GERMAN PERSPECTIVE

• The mechanics of centrally managed markets and the new challenges for the pharmaceutical industry

• The scientific foundation of market success: Where science meets sales is market access

• Why and how market access and MSLs have to work closely together to assure product success

• Communicating the dossier approved value message on all levels: MSLs and market access strategies

TOBIAS GANTNER, Head of Market Access, BAYER

4:45 REGULATIONS AND THE MSL ROLE: MAXIMALLY COMMUNICATING ESSENTIAL INFORMATION WITHOUT CROSSING ANY LINES

• Preparing to give information when it’s solicited – anticipating needs without influencing

• Mastering effective communication skills without crossing the line into sales

• How Does the NIH’s Health and Social Care Bill in the UK effect MSL Interactions?

LINCOLN TSANG, Partner, ARNOLD & PORTER LLP

5:30 Conference Concludes

EARLY BIRD PRICINGRegister by Friday, 16, September, 2011 to Take Advantage of Early-Bird Pricing: Conference + Workshop | €1695 Conference Only | €1495

STANDARD PRICINGRegister After Friday, 16 September, 2011 Conference + Workshop | €1895 Conference Only | €1695

ONSITE PRICING Conference + Workshop | €2095 Conference Only | €1895

Make checks payable to ExL Events, Inc. and write code P1132 on your check.

You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full prior to the commencement of the conference.

Register Now +1 -212-400 - 6240 | www.exlpharma.com/EuroMSL

ME

DIA

PA

RT

NE

RS

DELEGATE PROFILE FROM PREVIOUS EUROPEAN MSL BEST PRACTICES

CONFERENCE

Medical/Scientific Affairs

Medical Science Liaison

Other

REGISTRATION FEES FOR ATTENDING EXL’S

2ND EUROPEAN

Medical & Scientific ADVISOR Summit

and Best PracticesMSL 36OPM

THE FULL SPECTRUM OF PRODUCT MANAGEMENT36O

ExL Pharma, a division of ExL Events, Inc., is an industry leader in developing innovative, educational conferences that serve the pharmaceutical and allied healthcare communities in the United States, Europe and Latin America. Behind our diverse pharmaceutical event portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality events designed to exceed the dynamic informational and networking needs of specific audiences and working groups.

We organize over 60+ conferences per year that facilitate the exchange of critical information between industry executives and suppliers who support their scientific and commercial goals. Our pharmaceutical conferences are the preferred resource for industry professionals seeking important information and networking opportunities with a clear delineation between content and commercialism.

Our conferences have been a leading resource for industry executives to meet and network over key industry issues and to explore innovative products and services for over 6 years. We look forward to serving your informational and networking needs at a future industry event!

Driving innovation Through Leading Education

EARLY BIRD PRICINGBefore 16, September, 2011

€1695

€1495

STANDARD PRICINGAfter 16 September, 2011

€1895

€1695

Conference and Workshop

Conference only

Bringing Maximum Value to the KOL, Company, and Industry

Medical & Scientific ADVISOR

MSL Summit

2ND EUROPEAN

Best Practices

and

MSL2 0 - 2 1 O C T O B E R , 2 0 1 1 | K E M P I N S K I H O T E L B R I S T O L | B E R L I N , G E R M A N Y

ATTENTION MAILROOM: If undeliverable to addressee, please forward to Medical Science Liaison, Medical Affairs Director, Scientific/Medical Advisor

Name: Title:

Company:

Dept.:

Address:

City: State: Zip:

Email:

Telephone: Fax:

Please contact me: I’m interested in marketing opportunities at this event I wish to receive email updates on ExL Pharma’s upcoming events

Payment Type: MASTERCARD VISA DISCOVER AMEX

CHECK (Make checks payable to ExL Events, Inc.)

Card Number: Exp. Date:

Name on Card:

Signature:

Register me for...

Four Ways to RegisterMail: ExL Events, Inc. 555 8th Ave, Ste 310 New York, NY 10018

Phone: +1 212-400-6240

Online: www.exlpharma.com

Email: registration@exlpharma.com

Hotel Information: ExL Pharma is pleased to offer our delegates a limited number of hotel rooms at a discounted rate until Sept. 21, 2011. Please contact the hotel directly and mention "ExL Pharma October" conference to receive this rate.CONFERENCE VENUE: KEMPINSKI HOTEL BRISTOL BERLIN ADDRESS: KURFÜRSTENDAMM 27 10719 BERLIN, GERMANY RESERVATIONS: 49 3088 43 47 04

Cancellations: If you need to cancel your registration for an upcoming ExL conference, please note the following policies derived from the Start Date of the event:Four weeks or more: A full refund (minus a €95 processing fee), or a voucher to another ExL event valid for two years from the voucher issue date.Four weeks or Less: : A voucher to another ExL event valid for two years from the voucher issue date.To receive a refund or voucher, please fax your request to 888-221-6750.

Please Note: Conference registrations may be transferred to other colleagues in the event you are unable to attend. There will be an administrative charge of €300 to substitute, exchange and/or replace attendance badges with a colleague occurring within five business days of any ExL conference.Please notify ExL Pharma, info@exlpharma.com, prior to the event with the name and contact information of the replacement attendee.

Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, every effort to find a suitable replacement will be made.

*In the event of a cancellation or postponement ExL Events, Inc. will not be liable and/or responsible for any individual or group expenses related to said conference.

Group Discount Program: offers cannot be combined, early bird rates do not apply

Save 25% Per Person when Registering Four For every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the program (must register 4 at one time). This is a savings of 25% per person.

Save 15% per person when Registering Three Can only send three? You can still save 15% off of every registration. To find out more on how you can take advantage of these group discounts, please call +1-212-400-6240

PRIORITY CODE:

Regist rat ion Form

Yes! Register me for CONFERENCE CODE: P1132